| What is RSS feed? | About Us |
 |
 Search Score: 6/10
Source: news.google.com --- 14 hours ago
Drug stocks dip; Glaxo slides in wake of strategy update MarketWatch - 18 hours ago By Val Brickates Kennedy , , ) fell the day after it announced its new strategy for jump-starting profits. The Amex Pharmaceutical Index ($DRG: , , ) dipped 0.6% to 827.3. ... Source: au.rd.yahoo.com --- 1 day ago
WASHINGTON (Reuters) - AIDS patients should have a genetic test before treatment with GlaxoSmithKline Plc's drug Ziagen to see whether they face a higher risk of a potentially fatal reaction, U.S. regulators said on Thursday. ... Source: blogs.reuters.com --- 1 day ago
Diversification is the buzz word in pharmaceuticals as the feared 2010-2012 patent "cliff" looms nearer, when many of world's top medicines lose patent protection. New Glaxo CEO Andrew Witty, 43, is embracing the concept wholeheartedly via a bold deal with South Africa's Aspen that takes the world's second biggest drugmaker into generics in emerging markets and a strategy to broaden [...] ... Source: www.nytimes.com --- 1 day ago
Although all three firms face major threats from generic competition, results show that demand for medicines is holding up well at a time of economic downturn. ... Source: www.marketwatch.com --- 22 hours ago
BOSTON (MarketWatch) -- Drug stocks slipped modestly in early trading Thursday as shares of GlaxoSmithKline PLC fell the day after it announced its new strategy for jump-starting profits. The Amex Pharmaceutical Index was virtually flat at 304.7 and the Amex Biotechnology Index dipped 0.6% to 827.3. Glaxo shares dropped 3% to $47.36. On Wednesday, Glaxo announced that it plans to move away from developing huge "blockbuster" drugs and towards marketing vaccines, consumer products and generic drugs, especially in emerging markets. Glaxo made the announcement after it released a lackluster second-quarter earnings report. ... Source: blogs.wsj.com --- 3 hours ago
Doctors do it. Patients do it. Now GlaxoSmithKline is jumping into the self-publishing video game on YouTube. The company says it’s a way to talk more directly to the public. Glaxo, as were first learned from Pharmalot, posted a couple of corporate videos on YouTube earlier this month. In a previous foray on YouTube, Glaxo had [...] ... Source: www.marketwatch.com --- 1 day ago
Drug stocks gain in afternoon trading, though shares of GlaxoSmithKline PLC, the world's second-largest drugmaker, fall the day after it announces its new strategy for jump-starting profits. ... Source: www.moreover.com --- 1 day ago
Biz Journals Jul 24 2008 4:52PM GMT ... Source: www.moreover.com --- 1 day ago
International Herald Tribune Jul 24 2008 4:45PM GMT ... Source: www.manchestereveningnews.co.uk --- 1 day ago
THE new head of GlaxoSmith Kline said the drug giant must change to survive the growing threat of generic competition for its leading products. ... Source: www.bignewsnetwork.com --- 1 day ago
Africa's biggest generic drug maker, Aspen Pharmacare, has clinched a licensing and distribution deal with pharmaceutical giant GlaxoSmithKline that will see its products enter a host of new markets. ... Source: www.topix.com --- 1 day ago
GlaxoSmithKline has hit the US for its new general counsel, hiring Sidley Austin life sciences partner Dan Troy after a seven month search. ... Source: www.pharmalot.com --- 14 hours ago
The drugmaker has just launched its own channel on YouTube in a bid to polish its image, explain its purpose in life and, in Witty’s case, lure others to apply for work, even as some jobs are being eliminated (please look here and here). So far, only two videos can be seen, but in one, Witty [...] ... Source: www.fwicki.com --- 19 hours ago
July 23 (Bloomberg) -- Pfizer Inc .'s profit more than doubled as the company cut costs and boosted sales outside the U.S., while GlaxoSmithKline Plc and Wyeth failed to overcome losses to generic competition and reported lowered earnings. Pfizer ... ... Source: news.bbc.co.uk --- 2 days ago
Global drugs giant GlaxoSmithKline wants to broaden its product base as it grapples with tough competition from generic drug makers ... Source: online.wsj.com --- 2 days ago
GlaxoSmithKline unveiled a major strategy overhaul that will diversify its operations as it reported a slight rise in second-quarter net profit. ... Source: uk.reuters.com --- 2 days ago
LONDON (Reuters) - GlaxoSmithKline's new chief executive set out plans to make the world's second largest drugmaker a broader business with lower costs, but kept a cautious view on short-term prospects that knocked its shares. ... Source: online.wsj.com --- 1 day ago
Pfizer's profit more than doubled as international sales offset generic competition in the U.S. Glaxo posted a 3% drop in net and will cut costs. ...
Find more results for Glaxo on RSSMicro.com |
Copyright © 2008 RSSMicro.com
ChinaBio Today submits: GlaxoSmithKline (GSK) has made a strategic alliance with Aspen PharmaCare, a South African generic drug company, as a means of penetrating emerging markets such as China. GSK noted that 40% of the expected growth in pharmaceutical markets worldwide will be in emerging countries. The new strategy for GSK is a dramatic change from its traditional reliance on high-cost patented drugs. Instead, Glaxo is turning toward vaccines, OTC medications, consumer healthcare and, now, branded generic drugs. The blockbuster model that has traditionally been the basis for big pharma’s profits has fallen apart as the blockbuster drugs have lost their patent protection. Big pharma has been unable to develop new billion dollar medications to replace them. Complete Story » ...
GlaxoSmithKline today took a bold step into the branded generics market place through an alliance with South Africa's Aspen Pharmacare ...